Top section
Top section
◆ The threat of US corporate issuance to European borrowers ◆ The new funding environment for Middle East banks ◆ Reviving UK equity capital markets
Holdings down 16.4% from almost a quarter after institutional bookbuild and off-market buyback deal
Deal multiple times oversubscribed as investors buy into electrification and AI story
More articles
More articles
More articles
-
Biotechnology Research And Information Network priced and allocated its €32.5m initial public offering on Wednesday. The German biotech business is due to start trading in Frankfurt on February 9. -
The German lender can’t afford any further introspection after losing its place at the summit of European corporate finance, writes David Rothnie.
-
Caught between two regulatory initiatives, many small banks are unsure about whether to embark on the long and costly journey of developing their own regulatory capital models.
-
Myanmar held the first session of its new parliament this week, its first democratically elected legislature in over 50 years. The country is also preparing for a similarly rare event in its capital markets, with regulators set to name the first company to be allowed to float on the Yangon Stock Exchange (YSX). Jonathan Breen reports.
-
The stock of Chinese biopharmaceutical company BeiGene has shot up 18% on its first day of trading on the Nasdaq.
-
Goodbaby China Holdings has pulled its HK$1.3bn ($167.0m) Hong Kong IPO, deciding to cancel on the day it was due to price. Volatile markets and a weaker than expected book meant the leads decided to play it safe.
Sub-sections
shared comment list
